Literature DB >> 18817698

[Primary care physicians behaviour on hypertensive patients with poor blood pressure control. The PRESCAP 2006 study].

F J Alonso-Moreno1, J L Llisterri Caro, G C Rodríguez-Roca, M Ferreiro Madueño, D González-Segura Alsina, J A Divisón Garrote, J R Banegas, V Barrios Alonso, S Lou Arnal, T Sánchez Ruiz, J A Santos Rodríguez, R Durá Belinchón.   

Abstract

INTRODUCTION: There is little information available on Therapeutic Inertia in Primary Care (PC). This study aimed to know the therapeutic behavior of the physician for uncontrolled hypertensive patients. PATIENTS AND METHODS: Cross-sectional, multicenter study that included hypertensive patients of both genders, under pharmacological treatment who were recruited consecutively in the PC out-patient clinic in all of Spain. Social-demographic, clinical and treatment data were recorded, as well as the motives for eventual therapeutic modification. Adequate BP control was considered when BP values were below 140/90 mmHg in general, and below 130/80 mmHg in diabetes, renal insufficiency or cardiovascular disease.
RESULTS: A total of 10,520 patients (53.7% women) were included with average age of 64.6 (11.3 years). Of these, 44.4% the patients were receiving monotherapy and 55.6% were treated with combined therapy (two drugs 41.2%, three drugs 11.7%, and more than three 2.8%). Uncontrolled hypertension was found in 58.6% (95% CI. 57.6-59.5) of the patients. Treatment was modified by physicians in 30.4% (95% CI. 29.2-31.6) of the uncontrolled patients, combination with another drug being the most frequent behavior (46.3%), followed by dose increase (26.1%), and antihypertensive drug switch (22.8%). The perception of the physician of good BP control was the factor most associated with not modifying the treatment in uncontrolled patients.
CONCLUSIONS: Study results showed that the PC physician modified antihypertensive treatment in only 3 out of 10 uncontrolled patients. When treatment modification was made, association of drugs was the most frequent behavior.

Entities:  

Mesh:

Year:  2008        PMID: 18817698     DOI: 10.1157/13126341

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  6 in total

1.  Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial.

Authors:  Amy G Huebschmann; Trina Mizrahi; Alyssa Soenksen; Brenda L Beaty; Thomas D Denberg
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-16       Impact factor: 3.738

2.  Suitability of antiplatelet therapy in hypertensive patients.

Authors:  M J Martínez-Orozco; Z Perseguer-Torregrosa; V F Gil-Guillén; A Palazón-Bru; D Orozco-Beltran; C Carratalá-Munuera
Journal:  J Hum Hypertens       Date:  2014-04-03       Impact factor: 3.012

3.  [Objective KONTROL study: therapeutic inertia in hypertensive patients attended in primary care of Spain].

Authors:  Carlos Sanchis Doménech; José Luis Llisterri Caro; Vicente Palomo Sanz; Francisco Javier Alonso Moreno; Isidro López Rodríguez; Armando Nevado Loro; Miguel Ángel Zamorano; Natividad Gil García; M Dolores Aguilar Conesa; Pablo Lázaro Y de Mercado
Journal:  Aten Primaria       Date:  2011-03-17       Impact factor: 1.137

4.  Physician perception of blood pressure control and treatment behavior in high-risk hypertensive patients: a cross-sectional study.

Authors:  José R Banegas; Krista Lundelin; Mariano de la Figuera; Juan J de la Cruz; Auxiliadora Graciani; Fernando Rodríguez-Artalejo; Juan García Puig
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

5.  Hypertension Attitude PersPEctives and Needs (HAPPEN): A Real-World Survey of Physicians and Patients With Hypertension in China.

Authors:  Ross D Feldman; Lisheng Liu; Zhaosu Wu; Yuqing Zhang; Xueqing Yu; Xin-Hua Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-26       Impact factor: 3.738

6.  [Primary care evaluation of the hypertensive patient management in specialized care after derivation (DERIVA-2 Study)].

Authors:  Nieves Martell-Claros; Alberto Galgo Nafría; María Abad-Cardiel; Beatriz Álvarez-Álvarez; José Antonio García Donaire; Emilio Márquez-Contreras; Ángel Molino-González
Journal:  Aten Primaria       Date:  2017-10-14       Impact factor: 1.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.